{"id":6474,"date":"2020-01-02T16:40:00","date_gmt":"2020-01-02T15:40:00","guid":{"rendered":"https:\/\/www.gkm-therapieforschung.de\/event\/good-clinical-study-design\/"},"modified":"2020-01-02T16:58:04","modified_gmt":"2020-01-02T15:58:04","slug":"good-clinical-study-design","status":"publish","type":"tribe_events","link":"https:\/\/www.gkm-therapieforschung.de\/en\/event\/good-clinical-study-design\/","title":{"rendered":"Good Clinical Study Design"},"content":{"rendered":"<p><strong>Dr. Michael Obermeier,<\/strong> Head of Biostatistics at GKM, lectures at the FORUM seminar &#8220;Good Clinical Study Design&#8221;.<\/p>\n<p>The study design is the basis for the successful completion of a clinical trial. However, regulations, guidelines for patient safety, financial considerations and the practical feasibility set narrow limits to creativity. This seminar informs you about the regulatory framework and shows you how you should approach study planning and the definition of study design in a very practical way.<\/p>\n<ul>\n<li>What is the authority&#8217;s focus when assessing the design?<\/li>\n<li>How do you proceed methodically on the planning timeline?<\/li>\n<li>Which statistical considerations play a role?<\/li>\n<li>And how is the project assessed from an ethical perspective and in terms of patient safety?<\/li>\n<\/ul>\n<p>This seminar focuses on innovative and complex study designs such as adaptive, basket and umbrella, which are becoming increasingly important for clinical trials.<\/p>\n<p>Read more: <a href=\"https:\/\/www.forum-institut.de\/seminar\/2002242-good-clinical-study-design\">https:\/\/www.forum-institut.de\/seminar\/2002242-good-clinical-study-design<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Michael Obermeier, Head of Biostatistics at GKM, lectures at the FORUM seminar &#8220;Good Clinical Study Design&#8221;. <\/p>\n","protected":false},"author":37,"featured_media":0,"template":"","meta":{"_tribe_events_status":"","_tribe_events_status_reason":"","footnotes":""},"tags":[],"tribe_events_cat":[1011],"class_list":["post-6474","tribe_events","type-tribe_events","status-publish","hentry","tribe_events_cat-training-2","cat_training-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v14.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Good clinical study design | GKM Gesellschaft f\u00fcr Therapieforschung mbH<\/title>\n<meta name=\"description\" content=\"Dr. Michael Obermeier, Head of Biostatistics at GKM, lectures at the FORUM seminar &quot;Good Clinical Study Design&quot;. The study design is the basis for the successful completion of a clinical trial.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/good-clinical-study-design\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Good clinical study design | GKM Gesellschaft f\u00fcr Therapieforschung mbH\" \/>\n<meta property=\"og:description\" content=\"Dr. Michael Obermeier, Head of Biostatistics at GKM, lectures at the FORUM seminar &quot;Good Clinical Study Design&quot;. The study design is the basis for the successful completion of a clinical trial.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/good-clinical-study-design\/\" \/>\n<meta property=\"og:site_name\" content=\"GKM Gesellschaft f\u00fcr Therapieforschung mbH | Full-service CRO\" \/>\n<meta property=\"article:modified_time\" content=\"2020-01-02T15:58:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gkm-therapieforschung.de\/wp-content\/uploads\/2019\/11\/gkm-gesellschaft-fuer-therapieforschung.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#organization\",\"name\":\"GKM Gesellschaft f\\u00fcr Therapieforschung mbH\",\"url\":\"https:\/\/www.gkm-therapieforschung.de\/en\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.gkm-therapieforschung.de\/wp-content\/uploads\/2019\/11\/gkm-gesellschaft-fuer-therapieforschung.jpg\",\"width\":1200,\"height\":630,\"caption\":\"GKM Gesellschaft f\\u00fcr Therapieforschung mbH\"},\"image\":{\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#website\",\"url\":\"https:\/\/www.gkm-therapieforschung.de\/en\/\",\"name\":\"GKM Gesellschaft f\\u00fcr Therapieforschung mbH | Full-service CRO\",\"description\":\"Clinical Research Organization f\\u00fcr Auftragsforschung, klinische Studien und nicht-interventionelle Studien f\\u00fcr die Pharma und Medizinprodukte Industrie\",\"publisher\":{\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/www.gkm-therapieforschung.de\/en\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/good-clinical-study-design\/#webpage\",\"url\":\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/good-clinical-study-design\/\",\"name\":\"Good clinical study design | GKM Gesellschaft f\\u00fcr Therapieforschung mbH\",\"isPartOf\":{\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#website\"},\"datePublished\":\"2020-01-02T15:40:00+00:00\",\"dateModified\":\"2020-01-02T15:58:04+00:00\",\"description\":\"Dr. Michael Obermeier, Head of Biostatistics at GKM, lectures at the FORUM seminar \\\"Good Clinical Study Design\\\". The study design is the basis for the successful completion of a clinical trial.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/good-clinical-study-design\/\"]}]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","_links":{"self":[{"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events\/6474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/users\/37"}],"version-history":[{"count":3,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events\/6474\/revisions"}],"predecessor-version":[{"id":6478,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events\/6474\/revisions\/6478"}],"wp:attachment":[{"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/media?parent=6474"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tags?post=6474"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events_cat?post=6474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}